Early statistics regarding interest in unitary patent protection

No items found.
August 4, 2023
#
UPC

The EPO has recently added ‘Requests for unitary effect' to its Statistics & Trends Centre. The Statistics & Trends Centre provides a dashboard that now gives information about requests for unitary effect, including the associated areas of technology, language of proceedings, translation language, and origin of the (first named) proprietor of the patents.

English is a popular language of proceedings at the EPO (around 70% of unitary patents derive from European patents granted in English), and proprietors are commonly choosing to translate into Spanish or German, having the choice to file a translation into any EU official language. For patent applications where the procedural language was not English (around 30% of unitary patents), filing an English translation is the only option available.

In terms of country of origin, the statistics can be normalised to reflect the different numbers of patent applications filed by proprietors from different countries. Comparing the ‘Origin of proprietors' statistics from the dashboard with the number of granted patents by country in 2022 (2023 statistics are not available at the time of writing), it seems that the unitary patent is relatively more popular with European applicants. Given the limited time since the launch of the unitary patent system, the data is likely to be a bit noisy at this stage and may not be representative of the ultimate distribution. However, as things stand, UK, German, French, Italian and Dutch applicants are requesting unitary patents at roughly twice the rate of US, Japanese, Korean and Chinese applicants.

One can only speculate on the reasons for this – perhaps European companies and attorneys are responding more quickly to the change in the local legal landscape because it feels more relevant to them. These statistics may change with time as the largest patent applicants adapt and respond to behaviour of competitors.

The Statistics and Trends centre can be found here.

Recent Case Reports

Scripps mRNA reengineering patent found invalid and not infringed by Comirnaty
08 September 2026
The Local Division Munich invalidated Promosome's licensed mRNA patent over Scripps' codon-optimisation method, then found BioNTech's Comirnaty vaccine would not have infringed the claims even had they been valid.
Fujifilm v Kodak: clarifying the defence of dependent claims and inventive-step combinations at the UPC
27 August 2026
The Court of Appeal gave guidance on defending dependent claims, relying on EPO central limitation during UPC proceedings, and pleading revocation attacks. It also emphasised that inventive-step combinations require a proper pointer to the secondary reference.
Can Reference Numerals Influence Claim Interpretation?
21 August 2026
In T 0903/24, the EPO Board of Appeal relied on reference numerals to interpret disputed claim language, rejecting the patentee's narrower reading and revoking novelty over prior art D2 for the main request.